Earnings Per Share
EPS (Diluted, Continuing)
STERIS EPS (Diluted, Continuing) increased by 14.3% to $2.24 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.4%, from $1.48 to $2.24. Over 4 years (FY 2022 to FY 2026), EPS (Diluted, Continuing) shows an upward trend with a 28.6% CAGR.
Analysis
StatementIncome Statement
SectionEarnings Per Share
First reportedQ1 2022
Last reportedQ4 2026May 29, 2026
Metric ID:
axp_eps_diluted_continuing_operationsHistorical Data
20 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.73 | $0.73 | $0.73 | $0.73 | $1.19 | $1.24 | $1.31 | $1.83 | $1.31 | $1.20 | $1.49 | $1.54 | $1.41 | $1.51 | $1.75 | $1.48 | $1.79 | $1.94 | $1.96 | $2.24 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +64.1% | +4.2% | +5.6% | +39.7% | -28.4% | -8.4% | +24.2% | +3.4% | -8.4% | +7.1% | +15.9% | -15.4% | +20.9% | +8.4% | +1.0% | +14.3% |
| YoY Change | — | — | — | — | +64.1% | +71.0% | +80.7% | +152.4% | +10.1% | -3.2% | +13.7% | -15.8% | +7.6% | +25.8% | +17.4% | -3.9% | +27.0% | +28.5% | +12.0% | +51.4% |
Range$0.73 – $2.24
CAGR+26.8%
Avg YoY Growth+33.7%
Median YoY Growth+21.6%
Current Streak4 quarters growth
EPS (Diluted, Continuing) at Other Companies
Frequently Asked Questions
- What is STERIS's eps (diluted, continuing)?
- STERIS (STE) reported eps (diluted, continuing) of $2.24 in Q1 2026.
- How has STERIS's eps (diluted, continuing) changed year-over-year?
- STERIS's eps (diluted, continuing) increased by 51.4% year-over-year, from $1.48 to $2.24.
- What is the long-term trend for STERIS's eps (diluted, continuing)?
- Over 4 years (2022 to 2026), STERIS's eps (diluted, continuing) has grown at a 28.6% compound annual growth rate (CAGR), from $2.90 to $7.93.